Rayont Inc 's ability to collect accounts receivable sequentially worsen to 1.4, pointing to a challenging and on top of that deteriorating business climate for the Healthcare Facilities industry. Rayont Inc 's Accounts Receivable average collection period in the Mar 31 2023 quarter, has increased to 261 days, from 225 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 609 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 1558 to 3778.

What is Receivable Turnover Ratio?
What is Rayont Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RAYT Receivables Turnover Ratio	(Mar 31 2023) III. Quarter	(Dec 31 2022) II. Quarter	(Sep 30 2022) I. Quarter	(Jun 30 2022) IV. Quarter	(Mar 31 2022) III. Quarter
Y / Y Receivable Change	646.81 %	613.38 %	260.95 %	204.2 %	-38.24 %
Y / Y Revenue Change	110.98 %	110.48 %	99.07 %	109.12 %	-51.16 %
Receivable Turnover Ratio (TTM)	1.4	1.62	1.93	2.31	3.18
RAYT's Total Ranking	# 3778	# 1558	# 3547	# 3709	# 3613
Accounts Receivable average collection period days	261	226	189	158	115
Seq. Receivable Change	-5.76 %	16.62 %	8.7 %	525.09 %	-9.97 %
Seq. Revenue Change	-30.93 %	3.71 %	35.14 %	117.94 %	-31.09 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 48
Healthcare Sector	# 610
Overall Market	# 3778

Receivable Turnover Ratio Statistics
High	Average	Low
15.81	5.69	1.4
(Jun 30 2017)		(Mar 31 2023)

RAYT Company Profile • Back to RAYT Efficiency Comparisons • Compare RAYT Receivables Turnover Ratio to its Competitors

Financial Statements
Rayont Inc 's Accounts Receivable	$ 4 Millions	Visit RAYT's Balance sheet
Rayont Inc 's Sales TTM	$ 5 Millions	Visit RAYT's Income Statement
Sources of RAYT's Revenues		Visit RAYT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RAYT's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RAYT's Growth Rates	RAYT's Roa	RAYT's Inventory Turnover Ratio	RAYT's Dividend Comparisons
RAYT's Profitability Ratios	RAYT's Roi	RAYT's Asset Turnover Ratio	RAYT's Dividend Growth
RAYT's Valuation Ratios	RAYT's Roe	RAYT's Financial Strength Ratios	RAYT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Receivable at quarter ending Mar 31 2023
Retractable Technologies Inc	3.65	$ 59.931 Millions	$ 16.436 Millions
Bionexus Gene Lab Corp	3.65	$ 10.277 Millions	$ 2.819 Millions
Soligenix inc	3.62	$ 1.018 Millions	$ 0.281 Millions
Royalty Pharma Plc	3.61	$ 2,359.137 Millions	$ 654.111 Millions
Luna Innovations Inc	3.58	$ 112.061 Millions	$ 31.344 Millions
Inspiremd Inc	3.55	$ 5.062 Millions	$ 1.425 Millions
Marinus Pharmaceuticals Inc	3.55	$ 21.672 Millions	$ 6.110 Millions
Pixie Dust Technologies Inc	3.54	$ 5.182 Millions	$ 1.463 Millions
Assertio Holdings inc	3.51	$ 162.162 Millions	$ 46.260 Millions
Amneal Pharmaceuticals Inc	3.46	$ 2,258.884 Millions	$ 652.175 Millions
Nabriva Therapeutics Plc	3.41	$ 36.505 Millions	$ 10.697 Millions
Ginkgo Bioworks Holdings Inc	3.41	$ 390.003 Millions	$ 114.485 Millions
Sangui Biotech International Inc	3.38	$ 0.081 Millions	$ 0.024 Millions
Progyny Inc	3.35	$ 873.090 Millions	$ 260.303 Millions
Halozyme Therapeutics Inc	3.32	$ 704.980 Millions	$ 212.156 Millions
Eli Lilly And Company	3.30	$ 27,691.400 Millions	$ 8,394.550 Millions
Rennova Health Inc	3.29	$ 16.808 Millions	$ 5.112 Millions
Siga Technologies Inc	3.28	$ 108.559 Millions	$ 33.062 Millions
Viewray Inc	3.24	$ 121.598 Millions	$ 37.482 Millions
Pliant Therapeutics Inc	3.23	$ 9.768 Millions	$ 3.021 Millions
Solana Company	3.21	$ 0.779 Millions	$ 0.243 Millions
Collegium Pharmaceutical Inc	3.16	$ 596.134 Millions	$ 188.788 Millions
Sensus Healthcare Inc	3.15	$ 37.608 Millions	$ 11.935 Millions
Cardiff Oncology Inc	3.09	$ 2.046 Millions	$ 0.662 Millions
Seer Inc	3.03	$ 16.234 Millions	$ 5.362 Millions
Orchard Therapeutics Plc	3.02	$ 18.368 Millions	$ 6.076 Millions
Icad Inc	3.00	$ 26.199 Millions	$ 8.731 Millions
Ispecimen inc	2.98	$ 10.834 Millions	$ 3.634 Millions
Synlogic Inc	2.96	$ 1.110 Millions	$ 0.375 Millions
Smiledirectclub Inc	2.94	$ 438.874 Millions	$ 149.462 Millions

Date modified: 2023-05-17T03:28:14+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.